IRCT201107026930N1已完成2 期
Evaluation of anti-emetic efficacy of Aprepitant in patients undergo hematopoitic stem cell transplantation
Vice chancellor for research, Shahid Beheshti University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •patients who undergo autologus bone marrow transplantation. Exclusion criteria: severe hepatic and renal failure during drug administration; hypersensitivity to the drug.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Antiemetic effectiveness and safety of aprepitant in patients with lung cancer receiving combination therapy with carboplatin.lung cancerJPRN-UMIN000010018Hamamatsu University School of Medicine134
Unknown
3 期
Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction ChemotherapyChemotherapy Induced VomitingAcute Myeloid LeukemiaNCT02979548Dr Atul Sharma116
已完成
4 期
Investigation of the efficacy of an antiemetic, aprepitant and its drug interaction with prednisolone in CHOP or R-CHOP therapynon-Hodgkin lymphomaJPRN-UMIN000004495Division of Hematology, University of Tsukuba12
已完成
不适用
A Study to Evaluate the Efficacy of Anti-emetic Drug Upon the Combination Chemotherapy for Non-small Cell Lung CancerNon-small Cell Lung CancerNCT02364804Shiga University10
已完成
不适用
Evaluation of combinational effect of Aprepitant on nausea and vomiting induced by chemotherapy (moderate risk) in patients with Gastric Cancer or Colorectal CancerInoperable advanced/recurrence Gastric Cancer or Colorectal CancerJPRN-UMIN000008041Osaka Medical College Hospital100